Cancers | Feature Papers from the Second Half of 2024 in the Section “Cancer Pathophysiology”

As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the second half of 2024 in the “Cancer Pathophysiology” Section, which are listed below:

1. “Differential Diagnosis of Pigmented Lesions in the Oral Mucosa: A Clinical Based Overview and Narrative Review”
by Silvio Abati, Giacomo Francesco Sandri, Leonardo Finotello and Elisabetta Polizzi
Cancers 2024, 16(13), 2487; https://doi.org/10.3390/cancers16132487
Available online: https://www.mdpi.com/2072-6694/16/13/2487

2. “The Bright Side of Curcumin: A Narrative Review of Its Therapeutic Potential in Cancer Management”
by Andrea Amaroli, Isabella Panfoli, Matteo Bozzo, Sara Ferrando, Simona Candiani and Silvia Ravera
Cancers 2024, 16(14), 2580; https://doi.org/10.3390/cancers16142580
Available online: https://www.mdpi.com/2072-6694/16/14/2580

3. “Sex- and Age-Associated Differences in Genomic Alterations among Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)”
by ErinMarie O. Kimbrough, Julian A. Marin-Acevedo, Leylah M. Drusbosky, Ariana Mooradian, Yujie Zhao, Rami Manochakian and Yanyan Lou
Cancers 2024, 16(13), 2366; https://doi.org/10.3390/cancers16132366
Available online: https://www.mdpi.com/2072-6694/16/13/2366

4. “Precision Targeting Strategies in Pancreatic Cancer: The Role of Tumor Microenvironment”
by Nikolaos Vitorakis, Antonios N. Gargalionis, Kostas A. Papavassiliou, Christos Adamopoulos and Athanasios G. Papavassiliou
Cancers 2024, 16(16), 2876; https://doi.org/10.3390/cancers16162876
Available online: https://www.mdpi.com/2072-6694/16/16/2876

5. “Emerging Role of Hippo-YAP (Yes-Associated Protein)/TAZ (Transcriptional Coactivator with PDZ-Binding Motif) Pathway Dysregulation in Renal Cell Carcinoma Progression”
by Varsha Mondal, Paul J. Higgins and Rohan Samarakoon
Cancers 2024, 16(15), 2758; https://doi.org/10.3390/cancers16152758
Available online: https://www.mdpi.com/2072-6694/16/15/2758

6. “Efficacy of Cisplatin–CXCR4 Antagonist Combination Therapy in Oral Cancer”
by Saori Yoshida, Hotaka Kawai, Yamin Soe, Htoo Shwe Eain, Sho Sanou, Kiyofumi Takabatake, Yohei Takeshita, Miki Hisatomi, Hitoshi Nagatsuka, Junichi Asaumi et al.
Cancers 2024, 16(13), 2326; https://doi.org/10.3390/cancers16132326
Available online: https://www.mdpi.com/2072-6694/16/13/2326

7. “Lung Cancer Subtyping: A Short Review”
by Farzana Siddique, Mohamed Shehata, Mohammed Ghazal, Sohail Contractor and Ayman El-Baz
Cancers 2024, 16(15), 2643; https://doi.org/10.3390/cancers16152643
Available online: https://www.mdpi.com/2072-6694/16/15/2643

8. “Response Rates and Transplantation Impact in Patients with Relapsed Acute Promyelocytic Leukemia”
by Alessandro Costa, Carmelo Gurnari, Emilia Scalzulli, Laura Cicconi, Luca Guarnera, Ida Carmosino, Raffaella Cerretti, Maria Laura Bisegna, Saveria Capria, Clara Minotti et al.
Cancers 2024, 16(18), 3214; https://doi.org/10.3390/cancers16183214
Available online: https://www.mdpi.com/2072-6694/16/18/3214

9. “miRNAs Dysregulated in Human Papillomavirus-Associated Benign Prostatic Lesions and Prostate Cancer”
by Sandra Viridiana Salgado-Hernández, Lucero Martínez-Retamoza, Rodolfo Ocadiz-Delgado, Salvador Pérez-Mora, Gladys Edith Cedeño-Arboleda, María del Consuelo Gómez-García, Patricio Gariglio and David Guillermo Pérez-Ishiwara
Cancers 2025, 17(1), 26; https://doi.org/10.3390/cancers17010026
Available online: https://www.mdpi.com/2072-6694/17/1/26

10. “Profiling Plasma Extracellular Vesicle Metabotypes and miRNAs: An Unobserved Clue for Predicting Relapse in Patients with Early-Stage NSCLC”
by Vivi Bafiti, Eleni Thanou, Sotiris Ouzounis, Athanasios Kotsakis, Vasilis Georgoulias, Evi Lianidou, Theodora Katsila and Athina Markou
Cancers 2024, 16(22), 3729; https://doi.org/10.3390/cancers16223729
Available online: https://www.mdpi.com/2072-6694/16/22/3729

11. “Mutations Matter: Unravelling the Genetic Blueprint of Invasive Lobular Carcinoma for Progression Insights and Treatment Strategies”
by Athanasios Kontogiannis, Eleftheria Karaviti, Dimitra Karaviti, Sophocles Lanitis, Georgia Gomatou, Nikolaos K. Syrigos and Elias Kotteas
Cancers 2024, 16(22), 3826; https://doi.org/10.3390/cancers16223826
Available online: https://www.mdpi.com/2072-6694/16/22/3826

12. “Carcinoembryonic Antigen Expression in Human Tumors: A Tissue Microarray Study on 13,725 Tumors”
by Kristina Jansen, Lara Kornfeld, Maximilian Lennartz, Sebastian Dwertmann Rico, Simon Kind, Viktor Reiswich, Florian Viehweger, Ahmed Abdulwahab Bawahab, Christoph Fraune, Natalia Gorbokon et al.
Cancers 2024, 16(23), 4052; https://doi.org/10.3390/cancers16234052
Available online: https://www.mdpi.com/2072-6694/16/23/4052

13. “Double Heterozygosity for Germline Mutations in Chinese Breast Cancer Patients”
by Ava Kwong, Cecilia Yuen Sze Ho, Chun-Hang Au and Edmond Shiu-Kwan Ma
Cancers 2024, 16(14), 2547; https://doi.org/10.3390/cancers16142547
Available online: https://www.mdpi.com/2072-6694/16/14/2547

14. “Targeting the Leloir Pathway with Galactose-Based Antimetabolites in Glioblastoma”
by Martyn A. Sharpe, Omkar B. Ijare, Sudhir Raghavan, Alexandra M. Baskin, Brianna N. Baskin and David S. Baskin
Cancers 2024, 16(20), 3510; https://doi.org/10.3390/cancers16203510
Available online: https://www.mdpi.com/2072-6694/16/20/3510

15. “Prevalence and Prognostication of CD5+ Mature T-Cell Lymphomas”
by Omar Elghawy, Miao Cao, Jason Xu, Daniel J. Landsburg, Jakub Svoboda, Sunita D. Nasta, Elise A. Chong, Stephen J. Schuster, Colin J. Thomas, Jordan S. Carter et al.
Cancers 2024, 16(19), 3430; https://doi.org/10.3390/cancers16193430
Available online: https://www.mdpi.com/2072-6694/16/19/3430

You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office